OrbusNeich COMBO Dual Therapy Stent™: Routine Practice Registry Starts Enrolling

First Patients Enrolled in REMEDEE Registry to Evaluate Long-Term Safety and Performance of OrbusNeich's COMBO Dual Therapy Stent™ in Routine Practice (via PR Newswire)

Multicenter, All-Comers, Post-Market Registry to Enroll 1,000 Patients at Nine European Sites HONG KONG, Aug. 6, 2013 /PRNewswire/ — Patient enrollment has been initiated in a post-market registry for the COMBO Dual Therapy Stent to evaluate its long…